{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:50:29Z","timestamp":1779313829658,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.anl.2009.07.006","type":"journal-article","created":{"date-parts":[[2009,8,26]],"date-time":"2009-08-26T06:13:11Z","timestamp":1251267191000},"page":"199-204","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Angioedema: 6 years experience with fourteen cases"],"prefix":"10.1016","volume":"37","author":[{"given":"Masakatsu","family":"Taki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuhisa","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Bamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taketoshi","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Hisa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2009.07.006_bib1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0194-5998(99)70182-8","article-title":"Predicting airway risk in angioedema: staging system based on presentation","volume":"121","author":"Ishoo","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2009.07.006_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1067\/mhn.2000.107515","article-title":"Predictors of airway intervention in angioedema of the head and neck","volume":"123","author":"Zirkle","year":"2000","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2009.07.006_bib3","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1177\/000348940111000906","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema: a multicenter review and an algorithm for airway management","volume":"110","author":"Chiu","year":"2001","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.anl.2009.07.006_bib4","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.1988.03410070095035","article-title":"Clinical profile of angioedema associated with angiotensin-converting enzyme inhibition","volume":"260","author":"Slater","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.anl.2009.07.006_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.7326\/0003-4819-117-3-234","article-title":"Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology","volume":"117","author":"Israili","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anl.2009.07.006_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0009-9236(96)90161-7","article-title":"Black Americans have an increased rate of angiotensin converting inhibitor-associated angioedema","volume":"60","author":"Brown","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.anl.2009.07.006_bib7","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/01.CIR.0000075957.16003.07","article-title":"Cardiology patient page. What is an angiotensin converting enzyme inhibitor?","volume":"108","author":"Sweitzer","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.anl.2009.07.006_bib8","first-page":"153","article-title":"Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema","volume":"136","author":"Sabroe","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.anl.2009.07.006_bib9","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1097\/00005537-200110000-00011","article-title":"Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology","volume":"111","author":"Chiu","year":"2001","journal-title":"Laryngoscope"},{"key":"10.1016\/j.anl.2009.07.006_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-200225020-00001","article-title":"Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema?","volume":"25","author":"Howes","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.anl.2009.07.006_bib11","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1592\/phco.22.13.1176.33516","article-title":"Angioedema associated with candesartan","volume":"22","author":"Lo","year":"2002","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.anl.2009.07.006_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1345\/aph.1H566","article-title":"Olmesartan medoxomil-induced angioedema","volume":"41","author":"Nykamp","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.anl.2009.07.006_bib13","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1001\/archotol.130.12.1416","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists","volume":"130","author":"Kyrmizakis","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2009.07.006_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1161\/01.CIR.0000153269.07762.3B","article-title":"Losartan increases bradykinin levels in hypertensive humans","volume":"111","author":"Campbell","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.anl.2009.07.006_bib15","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2009.07.006_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM200208223470820","article-title":"Bradykinin-mediated angioedema","volume":"347","author":"Nussberger","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2009.07.006_bib17","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI200214211","article-title":"Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor","volume":"109","author":"Han","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.anl.2009.07.006_bib18","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archderm.1975.01630210056003","article-title":"Complement component analysis in angioedema: Diagnostic value","volume":"111","author":"Brasher","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.anl.2009.07.006_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1365-2125.2004.02268.x","article-title":"Increased C-reactive protein in ACE-inhibitor-induced angioedema","volume":"59","author":"Bas","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.anl.2009.07.006_bib20","first-page":"129","article-title":"\u00dcber akutes umshriebenes Haut\u00f6dem","volume":"1","author":"Quincke","year":"1882","journal-title":"Monatsh Prakt Dermatol"},{"key":"10.1016\/j.anl.2009.07.006_bib21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.otohns.2007.08.012","article-title":"Clinical experience with angiotensin-converting enzyme inhibitor-induced angioedema","volume":"137","author":"Grant","year":"2007","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2009.07.006_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1067\/mai.2002.121316","article-title":"Pathways for bradykinin formation and inflammatory disease","volume":"109","author":"Kaplan","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.anl.2009.07.006_bib23","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/oxfordjournals.jbchem.a124288","article-title":"Identification of mK1, a true tissue (glandular) kallikrein of mouse submandibular gland: tissue distribution and a comparison of kinin-releasing activity with other submandibular kallikreins","volume":"115","author":"Hosoi","year":"1994","journal-title":"J Biochem"},{"key":"10.1016\/j.anl.2009.07.006_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0024-3205(01)01129-8","article-title":"Induction of C-reactive protein, serum amyloid P component, and kininogens in the submandibular and lacrimal glands of rats with experimentally induced inflammation","volume":"69","author":"Wei","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.anl.2009.07.006_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/j.1552-4604.1996.tb04146.x","article-title":"Losartan: first of a new class of angiotensin antagonists for the management of hypertension","volume":"36","author":"Carr","year":"1996","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.anl.2009.07.006_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1055\/s-2001-16815","article-title":"Sonography in hereditary angioedema: typical findings demonstrated by the example of 3 cases","volume":"22","author":"Dirks","year":"2001","journal-title":"Ultraschall Med"},{"key":"10.1016\/j.anl.2009.07.006_bib27","series-title":"Atacand (candesartan cilexetil)","author":"Package insert","year":"2003"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814609001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814609001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:25:20Z","timestamp":1759951520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814609001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0385814609001576"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2009.07.006","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angioedema: 6 years experience with fourteen cases","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2009.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}